The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Cardiome Pharma Corp up $0.01

Cardiome Pharma Corp closed up Friday by $0.01 or 0.25% to $4.08. Shares have lost 1.21% over the last five days, but have gained 8.80% over the last year to date. This security has underperformed the S&P TSX by 42.88% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.06
Updated March 24 3:59 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-77.68%

Although this company's net profit margin is negative, it is above the industry average and implies that Cardiome Pharma Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.06%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue7567
Total other revenue--------
Total revenue7567
Gross profit5446
Total cost of revenue2121
Total operating expense129128
Selling / general / administrative9786
Research & development0000
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)001--
Other operating expenses, total--------
Operating income-5-4-6-1
Interest income (expense), net non-operating-1-100
Gain (loss) on sale of assets--------
Other--------
Income before tax-6-5-7-1
Income after tax-6-5-8-1
Income tax, total0000
Net income-6-5-8-1
Total adjustments to net income--------
Net income before extra. items-6-5-8-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-6-5-8-1
Inc. avail. to common incl. extra. items-6-5-8-1
Diluted net income-6-5-8-1
Dilution adjustment--------
Diluted weighted average shares32282020
Diluted EPS excluding extraordinary itemsvalue per share-0.18-0.19-0.37-0.06
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.18-0.19-0.32-0.06